PMID: 11312256Apr 20, 2001Paper

Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10

International Immunology
S KawamotoJ Miyazaki

Abstract

Insulin-dependent diabetes mellitus in the NOD mouse model is caused by the T cell-mediated autoimmune destruction of pancreatic beta cells. Viral IL-10 (vIL-10), encoded in the Epstein-Barr virus genome, shares many of the anti-inflammatory properties of cellular IL-10, but lacks its immunostimulatory properties. In the present study, we generated transgenic (Tg) NOD mice in which vIL-10 was produced exclusively in pancreatic islets and investigated the effect of vIL-10 on the development of diabetes. The accumulation of lymphocytes around islets was more prominent, but the invasive insulitis decreased in the vIL-10 Tg mice. The incidence of diabetes was markedly reduced in the vIL-10 Tg mice, in clear contrast to the accelerated diabetes seen in the murine IL-10 Tg NOD mice. IL-12p40 and IFN-gamma mRNA levels were decreased in pancreata of the vIL-10 Tg mice, although CD4 mRNA level was markedly increased. These results suggest that locally produced vIL-10 induced leukocyte migration, but inhibited the activation of T(h)1, probably through suppressing the production of IL-12. They indicate that vIL-10 may well be superior to cellular IL-10 in the treatment of autoimmune diabetes. The vIL-10 Tg NOD mice should provide a useful...Continue Reading

References

Jan 1, 1992·Advances in Immunology·H Kikutani, S Makino
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·F RoussetJ Banchereau
Oct 1, 1991·Immunological Reviews·T R MosmannD F Fiorentino
Feb 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N E Street, T R Mosmann
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P VieiraK W Moore
Feb 1, 1991·The Journal of Experimental Medicine·L Thompson-SnipesD M Rennick
Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
Oct 1, 1985·Transplantation·M GotohA P Monaco
Nov 1, 1985·Virology·G S HudsonB G Barrell
Aug 1, 1984·Journal of Biochemistry·K YamamuraT Kishimoto
Jan 1, 1980·Jikken dobutsu. Experimental animals·S MakinoY Tochino
Apr 1, 1994·European Journal of Immunology·F WillemsM Goldman
May 26, 1995·Science·J D KatzD Mathis
May 25, 1995·Nucleic Acids Research·M J GuimarãesT McClanahan
May 1, 1994·Clinical Immunology and Immunopathology·K J PennlineM Monahan
Dec 1, 1993·International Immunology·K TagaG Tosato
Aug 1, 1993·The Journal of Experimental Medicine·I MiyazakiH M Dosch
Apr 4, 1997·Cell·A V ChervonskyL A Matis
Feb 11, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Y NemotoY Niho

❮ Previous
Next ❯

Citations

Oct 14, 2003·Trends in Immunology·Matthias von Herrath, Dirk Homann
Nov 5, 2002·Current Opinion in Immunology·Natasha Hill, Nora Sarvetnick
Feb 14, 2002·Trends in Molecular Medicine·Luciano AdoriniLeonard C Harrison
Dec 7, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sang-Hoon Sin, Dirk P Dittmer
Nov 27, 2004·Diabetes Research and Clinical Practice·Eiji KawasakiKatsumi Eguchi
Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Urs ChristenMatthias G von Herrath
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zandong YangJerry L Nadler
Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M PhillipsA Cooke
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexandra Lucas, Grant McFadden
Oct 22, 2009·Science Signaling·Kohsuke YamazakiJun-ichiro Inoue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.